Becton Dickinson (BDX) Net Income towards Common Stockholders (2009 - 2026)
Becton Dickinson (BDX) posted quarterly Net Income towards Common Stockholders of -$274.0 million for Q1 2026, down 282.67% year-over-year from $150.0 million in Q1 2025, and down 171.73% quarter-over-quarter from $382.0 million in Q4 2025.
Becton Dickinson (BDX) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Net Income towards Common Stockholders for 18 consecutive years, with -$274.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders fell 282.67% year-over-year to -$274.0 million; the TTM figure through Mar 2026 stood at $1.2 billion (down 12.31% YoY), while the FY2025 annual figure was $1.7 billion, down 1.58% from the prior year.
- Net Income towards Common Stockholders fell to -$274.0 million in Q1 2026 per BDX's latest filing, from $382.0 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $574.0 million in Q2 2025 and bottomed at -$274.0 million in Q1 2026.
- Historically, Net Income towards Common Stockholders has averaged $340.6 million across 5 years, with a median of $392.0 million in 2023.
- Annual changes were most pronounced in 2024 — Net Income towards Common Stockholders surged 270.37% — and 2026, when it tumbled 282.67%.
- Becton Dickinson's Net Income towards Common Stockholders stood at $486.0 million in 2022, then slumped by 42.18% to $281.0 million in 2023, then increased by 7.83% to $303.0 million in 2024, then rose by 26.07% to $382.0 million in 2025, then plunged by 171.73% to -$274.0 million in 2026.
- Business Quant data shows BDX's Net Income towards Common Stockholders at -$274.0 million in Q1 2026, $382.0 million in Q4 2025, and $493.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 378.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 126.00 Mn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | 108.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -74.00 Mn |
| Mar 31, 2026 | -274.00 Mn |
| Dec 31, 2025 | 382.00 Mn |
| Sep 30, 2025 | 493.00 Mn |
| Jun 30, 2025 | 574.00 Mn |
| Mar 31, 2025 | 150.00 Mn |
| Dec 31, 2024 | 303.00 Mn |
| Sep 30, 2024 | 400.00 Mn |
| Jun 30, 2024 | 487.00 Mn |
| Mar 31, 2024 | 537.00 Mn |
| Dec 31, 2023 | 281.00 Mn |
| Sep 30, 2023 | 108.00 Mn |
| Jun 30, 2023 | 392.00 Mn |
| Mar 31, 2023 | 438.00 Mn |
| Dec 31, 2022 | 486.00 Mn |
| Sep 30, 2022 | 265.00 Mn |
| Jun 30, 2022 | 338.00 Mn |
| Mar 31, 2022 | 431.00 Mn |
| Dec 31, 2021 | 655.00 Mn |
| Sep 30, 2021 | 242.00 Mn |